— Know what they know.
Not Investment Advice
Also trades as: 0013.HK (HKSE) · $vol 10M · HCM (NASDAQ) · $vol 0M · HCM.L (LSE) · $vol 0M

HMDCF OTC

HUTCHMED (China) Limited
1W: +0.0% 1M: +0.0% 3M: -23.4% YTD: -41.0% 1Y: -32.5% 3Y: -11.8% 5Y: -57.7%
$2.90
+0.74 (+34.26%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 35 · $2.5B mcap · 514M float · 0.0000% daily turnover · Short 100% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$2.5B
52W Range2.16-3.815
Volume468
Avg Volume2
Beta0.43
Dividend
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOChig Fung Cheng
Employees1,796
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-04-17
Cheung Kong Center
Hong Kong
HK
852 2128 1188
About HUTCHMED (China) Limited

HUTCHMED (China) Ltd. operates as a holding company, specializing in the research, development, manufacturing, and sales of both pharmaceutical products and health-focused consumer goods. The company's operations are divided into two main segments: Oncology/Immunology and Other Ventures. The Oncology/Immunology division is dedicated to the discovery, development, and commercialization of targeted therapies and immunotherapies aimed at treating cancer and immunological diseases. In contrast, the Other Ventures segment handles the company's other commercial activities, which include the marketing, production, and distribution of prescription medications and general healthcare products. Established on December 18, 2000, the company maintains its headquarters in Hong Kong.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms